Related Experiment Video
Updated: May 27, 2026
06:39
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Prevention of recurrent postpartum depression a reasonable option?
The Israel Journal of Psychiatry and Related Sciences
|November 29, 2011
Summary
This case discusses preventive treatment for postpartum depression (PPD) in a woman with a history of PPD. It explores options for managing depression risk during her second pregnancy and after childbirth.
Area of Science:
- Reproductive psychiatry
- Perinatal mental health
Background:
- A 27-year-old woman, 32 weeks pregnant, has a history of postpartum depression (PPD).
- She experienced PPD after her first childbirth but has been asymptomatic since successful antidepressant treatment.
Purpose of the Study:
- To evaluate the clinical dilemma of preventive depression treatment for a pregnant woman with a history of PPD.
- To determine the best course of action for managing PPD risk in this patient.
Main Methods:
- Case report analysis
- Review of treatment guidelines for recurrent PPD
- Consultation on pharmacologic and non-pharmacologic interventions
Main Results:
- The patient's history of PPD and successful treatment indicates a significant risk for recurrence.
- Preventive strategies may include continuation or re-initiation of antidepressants.
- Non-pharmacologic support and monitoring are crucial.
Conclusions:
- Proactive management is essential for women with a history of PPD.
- Personalized treatment plans should be developed to mitigate the risk of postpartum depression.
- Further research is needed on long-term preventive strategies in pregnancy.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...